FDA Inspection
Teva Canada LimitedTeva Canada Limited – FDA Inspection, Jul 29, 2010
Record Details
This FDA Inspection record concerns Teva Canada Limited, with an inspection on July 29, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Teva Canada Limited
- Inspection Date
- July 29, 2010
- Product Type
- Drugs
View Company Profile
ID · f0e62f85-9d26-4ae8-9331-4dca75d9c985
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 680578
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.94(c)Containers & Closures Clean, Sterilized, Pyrogen-free
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Teva Canada Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| April 26, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 18, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Canada Limited
- FDA Inspection 1265556 - 2025-04-24
- FDA Inspection 1092488 - 2019-04-26
- FDA Inspection 992270 - 2016-11-18
- FDA Inspection 868166 - 2014-02-21
- FDA Inspection 750624 - 2011-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.